Veracyte Raises FY23 Revenue From $342M-$350M To $352M-$354M Vs $346.89M Est.
Portfolio Pulse from Benzinga Newsdesk
Veracyte has increased its full-year 2023 total revenue guidance from $342M-$350M to $352M-$354M, representing a year-over-year growth of approximately 19%. This is an improvement compared to the prior guidance of $342M-$350M.
November 08, 2023 | 1:31 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Veracyte has raised its FY23 revenue guidance, indicating a positive outlook for the company's financial performance.
Veracyte's raised revenue guidance for FY23 indicates that the company expects stronger financial performance than previously anticipated. This could potentially lead to a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100